Anticipatory AI Intelligence for Pharma
See the assets, risks, and opportunities before the market moves.
Why Pharma Needs
Anticipatory Intelligence.
Data has become too vast, too fast, and too fragmented for reactive strategy.
Every week brings thousands of new filings, trial updates, patents, competitive signals, and regulatory shifts—each capable of shaping price, terms, protocol, or partner.
BIOPTIC provides unlimited AI analysts that digest global filings, trials, and patents in 100+ languages in hours—not months.
Bioptic Turns Global Noise
Into Usable Foresight.
The first company to spot an overlooked asset, or a hidden risk, wins. BIOPTIC gives you that advantage by scanning global filings and trials faster than any human team ever could. Timing sets price, terms, protocol and partnerships.
Quality is all that matters
This is not ChatGPT repurposed for pharma. BIOPTIC Agents are trained only on pharma-specific, clean, curated data and constantly check themselves to eliminate hallucinations. They work with the rigor and process of a scientist, collaborating with humans to ensure they’re on the right track.
Our AI’s business is your business
The bottleneck in biopharma isn’t just science - it’s deep research, scouting, due diligence, commercialization. BIOPTIC agents de-risk and accelerate all these labor-intensive processes, extracting hard data from patents and press releases, analyzing scientific papers, and checking the pipeline of every biotech in the world.
Building the hub and the spokes
BIOPTIC Agents can form an autonomous AI "hub" in a new vision of hub-and-spoke pharma, automating routine tasks and leaving human executives to focus on the most important responsibilities: making investment decisions, building relationships, and fundraising.
Get in touch
Whether you’re a researcher, potential partner, or just curious about what we’re building, drop us a message. Explore how we can push the boundaries of science and discovery.